Skip to main content
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Clinical Diabetes
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Spectrum

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Clinical Diabetes
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Spectrum
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
Departments

Smart Connected Insulin Pens, Caps, and Attachments: A Review of the Future of Diabetes Technology

  1. Nikhil A. Sangave1,
  2. Timothy D. Aungst2 and
  3. Dhiren K. Patel1
  1. 1MCPHS University, Boston, MA
  2. 2MCPHS University, Worcester, MA
  1. Corresponding author: Dhiren K. Patel, dhiren.patel1{at}mcphs.edu
Diabetes Spectrum 2019 Nov; 32(4): 378-384. https://doi.org/10.2337/ds18-0069
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Tables

  • TABLE 1.

    Overview of InPen, ESYSTA, Pendiq, and YpsoMate SmartPilot Smart Insulin Pens

    InPenESYSTAPendiqYpsoMate SmartPilot
    CompanyCompanion MedicalEmperraPendiqYpsoMed
    Country of originUnited StatesGermanyGermanySwitzerland
    FDA approval2016NoNoNo
    U.S. availabilityYesNoNoNo
    Cost$665$220 (€192)*$193 (€169)*Unable to verify
    Insulin compatibilitiesLispro/aspart 3-mL cartridgesLispro/aspart/glulisine 3-mL cartridgesLispro/aspart 3-mL cartridgesPrefilled insulin
    App serviceApple, AndroidApple, AndroidApple, AndroidUnable to verify
    BluetoothYesYesYesYes
    USBNoNoYesNo
    Features• Lasts 1 year
    • Temperature sensor
    • Dose calculator
    • Reminders for patient
    • Prescription needed
    • Cloud database accessible to providers
    • Replaceable batteries (last for up to 1 year)
    • Memory capacity for 1,000 data records
    • Memory for recording last 1,000 injections (date, time, quantity)
    • Alarms if low battery, needle blockage, or low insulin
    • Rechargeable battery
    • Tracks injection time and sequence of handling (pressing against skin, triggering the injection, positioning the injector, end of injection)
    • ↵* Currency conversions conducted on 29 January 2019.

  • TABLE 2.

    Overview of NovoPen 5 Plus, NovoPen Echo, Vigipen, and KiCoPen Smart Insulin Pens

    NovoPen 5 PlusNovoPen EchoVigipenKiCoPen
    CompanyNovo NordiskNovo NordiskDiabnextCambridge Consultants
    Country of originUnited StatesUnited StatesUnited StatesUnited Kingdom
    FDA approvalNoYesNoNo
    U.S. availabilityNoYesNoNo
    Cost$68 (∼£52)*∼$54–$67 with discountUnable to verifyUnable to verify
    Insulin compatibilitiesAspart 3-mL cartridgesAspart 3-mL cartridgesUnable to verifyUnable to verify
    App serviceNoNoAppleUnable to verify
    BluetoothNoNoYesUnable to verify
    USBNoNoNoUnable to verify
    Features• Records time since and dose of last injection
    • Displays battery life and memory status
    • Designed for children
    • Records time since and dose of last injection
    • Displays battery life and memory status
    • Half-unit dosing
    • Automatically records the time of injection as well as the amount of insulin injected
    • Transfers the data via Bluetooth to app
    • Records time and amount injected
    • ↵* Currency conversions conducted on 29 January 2019.

  • TABLE 3.

    Overview of Smart Caps

    GoCapTimesulinDukada Trio
    CompanyCommon SensingBigfoot BiomedicalDukada
    Country of originUnited StatesUnited KingdomDenmark
    Year created201320102012
    FDA approvalNoNoNo
    U.S. availabilityYesNoNo
    Cost$25/month$15.72 (∼£12)*$46 (∼ €40)*
    Insulin compatibilitiesSoloStar pens, FlexPen, and KwikPen (2019) pensKwikPen, FlexPen, FlexTouch, SoloStar pensFlexPen, SoloStar pens
    App serviceApple, AndroidNoNo
    BluetoothYesYesNo
    USBYesNoNo
    Features• Displays remaining insulin
    • App displays type/time of insulin administration
    • App allows for blood glucose monitoring and meal entry
    • Lasts 1 year
    • Tracks the time since last injection
    • Battery life of 1 year
    • Flexible grip allows for more stability
    • Has a light above needle for better visibility
    • Shows time elapsed since last injection
    • ↵* Currency conversions conducted on 29 January 2019.

  • TABLE 4.

    Overview of Insulin Pen Attachments

    InsulClockClipsulinEasyLogInsulCheck
    CompanyInsulCloudDiabnextBioCorpInnovation Zed, Ltd.
    Country of originSpainUnited StatesFranceIreland
    FDA approvalNoNoNoNo
    U.S. availabilityNoNoNoNo
    Cost$285 (€249)*∼$40<$50∼$32
    Insulin compatibilitiesKwikPen, FlexTouch, SoloStar pensSoloStar pens, ClikSTAR, KwikPen, Luxura, FlexPen, FlexTouchUnable to verifyFlexPen, KwikPen, SoloStar pens, NovoPen 3/4/5/Echo, Luxura HD, Savvio, ClikSTAR
    App serviceApple, AndroidApple, AndroidUnable to verifyNo
    BluetoothYesYesYesNo
    USBNoNoNoNo
    Features• Shows the type, time, and quantity of insulin administered
    • App provides dose reminders, food/glucose input, temperature fluctuations
    • Shows the type, time, and quantity of insulin administered
    • Battery life of 1,800 injections
    • Memory of 200 injections
    • Detects time, date, amount of insulin injected
    • Alerts patients about missed, extra, and next doses
    • Records elapsed time between injections
    • Green light flashes when dose injected
    • Temperature sensor
    • Replaceable battery
    • ↵* Currency conversions conducted on 29 January 2019.

PreviousNext
Back to top
Diabetes Spectrum: 32 (4)

In this Issue

November 2019, 32(4)
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Spectrum.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Smart Connected Insulin Pens, Caps, and Attachments: A Review of the Future of Diabetes Technology
(Your Name) has forwarded a page to you from Diabetes Spectrum
(Your Name) thought you would like to see this page from the Diabetes Spectrum web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Smart Connected Insulin Pens, Caps, and Attachments: A Review of the Future of Diabetes Technology
Nikhil A. Sangave, Timothy D. Aungst, Dhiren K. Patel
Diabetes Spectrum Nov 2019, 32 (4) 378-384; DOI: 10.2337/ds18-0069

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Smart Connected Insulin Pens, Caps, and Attachments: A Review of the Future of Diabetes Technology
Nikhil A. Sangave, Timothy D. Aungst, Dhiren K. Patel
Diabetes Spectrum Nov 2019, 32 (4) 378-384; DOI: 10.2337/ds18-0069
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Digital Health Advancements for Insulin Pens
    • Discussion
    • Duality of Interest
    • Author Contributions
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

Departments

  • Brief Literature Review: The Potential of Diabetes Technology to Improve Sleep in Youth With Type 1 Diabetes and Their Parents: An Unanticipated Benefit of Hybrid Closed-Loop Insulin Delivery Systems
  • Mental Health and Behavioral Screening in Pediatric Type 1 Diabetes
Show more Departments

Care Innovations

  • Leveraging Mechanical Forces to Target Insulin Injection–Induced Lipohypertrophy and Fibrosis
  • Development and Implementation of the Readiness Assessment of Emerging Adults With Type 1 Diabetes Diagnosed in Youth (READDY) Tool
Show more Care Innovations

Similar Articles

Navigate

  • Current Issue
  • Papers in Press
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Diabetes Care
  • Clinical Diabetes
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Spectrum Print ISSN: 1040-9165, Online ISSN: 1944-7353.